Tag: Kiniksa Pharmaceuticals Ltd

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Kiniksa Pharmaceuticals Ltd

Vanguard Group Inc Acquires 405991 Shares of Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

Added to Collection on: 2019-02-10 20:33:45

Tags for this article:

Monoclonal antibodies
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Vanguard Group Inc Has $14.18 Million Stake in Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

Added to Collection on: 2019-02-18 14:00:00

Tags for this article:

Money
Finance
Economy
Short
Pharmaceuticals policy
Pharmaceutical industry in China
Science and technology in the People's Republic of China
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Announces Data from US Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 ...

Added to Collection on: 2020-12-22 12:56:15

Tags for this article:

Health sciences
Health
Clinical research
COVID-19 drug development
Design of experiments
COVID-19
Pharmaceutical industry
Remdesivir
Mechanical ventilation
Mavrilimumab
Placebo-controlled study
Clinical trial
GM-CSFR
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
What Kind Of Investors Own Most Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)?

Added to Collection on: 2021-01-02 14:26:15

Tags for this article:

Finance
Financial markets
Money
Corporate finance
Stock market
Equity securities
Alternative investment management companies
Hedge fund
Stock
Short
Common stock
Insider trading
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Brokers Set Expectations for Kiniksa Pharmaceuticals, Ltd.'s Q1 2022 Earnings (NASDAQ:KNSA)

Added to Collection on: 2021-02-25 13:30:00

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Corporate finance
Share
Stock
Price?earnings ratio
Reverse stock split
Short
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals Ltd. (KNSA) – Don't Be So Quick to Call it Dead

Added to Collection on: 2021-03-19 21:45:00

Tags for this article:

Financial markets
Finance
Stock market
Financial economics
Stock
Short
NASDAQ
Volume
Insider trading
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
-$0.74 Earnings Per Share Expected for Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) This Quarter

Added to Collection on: 2021-04-24 08:48:45

Tags for this article:

Finance
Financial markets
Money
Financial ratios
Corporate finance
Stock market
Fundamental analysis
Price?earnings ratio
Short
Cannabis industry
Earnings per share
Stock
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Sees Large Increase in Short Interest

Added to Collection on: 2025-03-05 18:16:03

Tags for this article:

Equity securities
House of Morgan
JPMorgan Chase
Stock
Short
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring A 35.96% Potential Upside ...

Added to Collection on: 2025-07-08 13:10:44

Tags for this article:

Biopharmaceutical
Biotechnology
Pharmaceutical industry
Pharmacy
Pharmaceutical industry in China
Investment
Pericarditis
MACD
Vixarelimab
Product pipeline
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Biopharma Gem With 27.60 ...

Added to Collection on: 2025-10-08 02:01:32

Tags for this article:

Biopharmaceutical
Biotechnology
Pharmaceutical industry
Pharmacy
Product pipeline
Pharmaceutical industry in India
Pharmaceutical industry in China
Kiniksa Pharmaceuticals Ltd

Click the tags to see associated articles and topics

View Article Details
Book a Demo